ESGEX Performance — Reynders, McVeigh Core Equity Fund, Institutional Shares
Data updated: 2026-09-29
ESGEX returned +2.95% year to date and +8.46% over one year to Jul 2026. Annualised returns are +12.02% over 3 years and +5.33% over 5 years. The fund trailed its US Large Blend category average: $100 invested three years ago grew to $141, against $153 for the category, and to $108 over one year, against $116. Volatility over the past three years was 14.90% a year. In the 12 months to Jul 2026 the fund took in a net $9.9M, and assets reached $106.80M.
ESGEX Growth of $100
What $100 invested in Reynders, McVeigh Core Equity Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Blend category average over the same months.
| Period | ESGEX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $108 | $116 |
| 3 years (Aug 2023 – Jul 2026) | $141 | $153 |
| 5 years (Aug 2021 – Jul 2026) | $130 | $159 |
| Since data start (Feb 2020 – Jul 2026) | $225 | $213 |
ESGEX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +2.95% |
| 1 year | +8.46% |
| 3 years (annualised) | +12.02% |
| 5 years (annualised) | +5.33% |
ESGEX Annual Returns
Calendar-year total returns of Reynders, McVeigh Core Equity Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +2.95% |
| 2025 | +18.26% |
| 2024 | +14.01% |
| 2023 | +18.49% |
| 2022 | −23.44% |
| 2021 | +18.06% |
| 2020 (Feb–Dec) | +51.29% |
ESGEX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.8% | −0.2% | −8.4% | +7.3% | +4.7% | +1.5% | −2.0% | — | — | — | — | — |
| 2025 | +4.1% | 0.0% | −5.7% | +1.4% | +6.2% | +5.9% | +0.3% | +0.7% | +3.1% | +2.3% | +0.6% | −1.4% |
| 2024 | −0.8% | +6.5% | +2.0% | −3.6% | +5.8% | +0.9% | +3.2% | +2.3% | +1.4% | −3.1% | +3.5% | −4.4% |
| 2023 | +6.7% | −1.4% | +3.2% | −0.9% | −2.2% | +7.1% | +3.8% | −3.8% | −5.4% | −5.9% | +10.6% | +6.9% |
| 2022 | −9.8% | −1.6% | +2.2% | −9.8% | −0.8% | −8.2% | +12.0% | −6.0% | −10.0% | +7.0% | +7.7% | −5.8% |
| 2021 | +2.9% | +0.1% | +0.1% | +3.6% | +0.9% | +4.3% | +2.1% | +3.3% | −6.9% | +6.5% | −1.3% | +1.9% |
| 2020 | — | −0.1% | −0.1% | +0.1% | +8.3% | +3.0% | +7.8% | +7.3% | −1.9% | −1.4% | +12.8% | +7.5% |
ESGEX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 14.90%
- 3-year Sharpe ratio: 0.50 (vs 4.5% risk-free rate)
- Best month: +10.60% (Nov 2023)
- Worst month: −8.38% (Mar 2026)
ESGEX Fund Flows
Monthly money in and out of Reynders, McVeigh Core Equity Fund, from SEC Form N-PORT.
- 12-month net flow: $9.9M
- 12-month gross sales (incl. reinvestments): $18.5M
- Sales ÷ redemptions: 2.17×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $567K | $544K | $23K |
| Jun 2026 | $1.1M | $691K | $386K |
| May 2026 | $725K | $452K | $273K |
| Apr 2026 | $773K | $156K | $617K |
| Mar 2026 | $2.4M | $926K | $1.4M |
| Feb 2026 | $530K | $55K | $475K |
| Jan 2026 | $1.8M | $510K | $1.3M |
| Dec 2025 | $6.1M | $3.4M | $2.7M |
| Nov 2025 | $1.9M | $552K | $1.3M |
| Oct 2025 | $1.1M | $292K | $829K |
| Sep 2025 | $958K | $610K | $348K |
| Aug 2025 | $580K | $347K | $233K |
ESGEX Assets Under Management
Net assets of Reynders, McVeigh Core Equity Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $106.80M |
| 2026-04-30 | $101.88M |
| 2026-01-31 | $101.17M |
| 2025-10-31 | $100.93M |
| 2025-07-31 | $93.69M |
| 2025-04-30 | $83.01M |
| 2025-01-31 | $87.03M |
| 2024-10-31 | $86.92M |
| 2024-07-31 | $85.70M |
| 2024-04-30 | $76.03M |
| 2024-01-31 | $70.46M |
| 2023-10-31 | $60.42M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.